Drugs / Influenza VLP Vaccine (recombinant)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00754455 | Sep 2008 → Mar 2009 | influenza | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza VLP Vaccine (recombinant) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00754455 ↗ |
| Modality | Vaccine | “Influenza VLP Vaccine (recombinant)” NCT00754455 ↗ |
| Route | Intramuscular | “a single intramuscular (IM) injection of Influenza VLP Vaccine or placebo” NCT00754455 ↗ |